| Literature DB >> 30928194 |
Feng Wang1, Quan-Bing Zhang1, Yun Zhou2, Shuang Chen1, Peng-Peng Huang1, Yi Liu1, Yuan-Hong Xu3.
Abstract
The clinical treatment of joint contracture due to immobilization remains difficult. The pathological changes of muscle tissue caused by immobilization-induced joint contracture include disuse skeletal muscle atrophy and skeletal muscle tissue fibrosis. The proteolytic pathways involved in disuse muscle atrophy include the ubiquitin-proteasome-dependent pathway, caspase system pathway, matrix metalloproteinase pathway, Ca2+-dependent pathway and autophagy-lysosomal pathway. The important biological processes involved in skeletal muscle fibrosis include intermuscular connective tissue thickening caused by transforming growth factor-β1 and an anaerobic environment within the skeletal muscle leading to the induction of hypoxia-inducible factor-1α. This article reviews the progress made in understanding the pathological processes involved in immobilization-induced muscle contracture and the currently available treatments. Understanding the mechanisms involved in immobilization-induced contracture of muscle tissue should facilitate the development of more effective treatment measures for the different mechanisms in the future.Entities:
Keywords: Disuse skeletal muscle atrophy; Immobilization-induced joint contracture; Skeletal muscle fibrosis; Treatment
Mesh:
Substances:
Year: 2019 PMID: 30928194 PMCID: PMC6488749 DOI: 10.1016/j.cjtee.2019.02.001
Source DB: PubMed Journal: Chin J Traumatol ISSN: 1008-1275